Clinical Research Directory
Browse clinical research sites, groups, and studies.
Photodynamic Therapy Incubation Times for Actinic Keratosis
Sponsor: Northwestern University
Summary
This is a randomized clinical trial evaluating blue light 5-aminolevulinic acid (ALA) photodynamic therapy with different incubation times for the treatment of actinic keratosis. Subjects who are interested in participating, currently living in the Chicago metropolitan area, and meet inclusion and exclusion criteria will be enrolled in the study. Subjects will be randomized to either 1) zero time ALA incubation or 2) 1 hour ALA incubation. Demographic and health data will be collected prior to treatment initiation. Three visits will be conducted: screening, treatment, and follow up visit at 8 weeks. This study is a pilot study designed to determine feasibility of this procedure.
Official title: A Randomized Controlled Trial Evaluating 5-aminolevulinic Acid Photodynamic Therapy With Different Incubation Times for the Treatment of Actinic Keratosis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2017-03-01
Completion Date
2025-12
Last Updated
2025-01-31
Healthy Volunteers
Yes
Conditions
Interventions
ALA (5-aminolevulinic acid)
ALA (5-aminolevulinic acid) will be applied to subjects' skin for either zero time incubation or one hour incubation
Blue light therapy
Subjects will be exposed to blue light
Locations (1)
Northwestern University Feinberg School of Medicine, Department of Dermatology
Chicago, Illinois, United States